Fumiaki Tanaka

Fumiaki Tanaka

Auto-generated profile, based on publicly available information

Fumiaki Tanaka

Department of Surgery, Kyushu University Beppu Hospital, 4546 Tsurumihara, Beppu, 874-0838, Japan

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2002
Verified
Journal Article
Closed access
KMKohjiro Mashino
Kohjiro Mashino
NSNoriaki Sadanaga
Noriaki Sadanaga
HYHiroshi Yamaguchi
Hiroshi Yamaguchi
FTFumiaki Tanaka
Fumiaki Tanaka
MOMitsuhiko Ohta
Mitsuhiko Ohta
MMMasaki Mori
Masaki Mori

9 April 2011 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
HHHajime Hirose
Hajime Hirose
HIHideshi Ishii
Hideshi Ishii
KMKoshi Mimori
Koshi Mimori
FTFumiaki Tanaka
Fumiaki Tanaka
ITIchiro Takemasa
Ichiro Takemasa
MMMasaki Mori
Masaki Mori

18 January 1999 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
TFTatsuo Fujie
Tatsuo Fujie
KTKouichirou Tahara
Kouichirou Tahara
FTFumiaki Tanaka
Fumiaki Tanaka
MMMasaki Mori
Masaki Mori
KTKazutou Takesako
Kazutou Takesako
TATsuyoshi Akiyoshi
Tsuyoshi Akiyoshi

28 December 2009 in Oncology Reports
Verified
Journal Article
Closed access
PDF file
MOMori
Mori
NMNorikatsu Miyoshi
Norikatsu Miyoshi
HIHideshi Ishii
Hideshi Ishii
KMKoshi Mimori
Koshi Mimori
FTFumiaki Tanaka
Fumiaki Tanaka
MMMasaki Mori
Masaki Mori
The adenosine triphosphate-binding cassette transporter-homologous gene ATP11A belongs to an extended family of adenosine triphosphate-binding cassette transporters. We analysed the ATP11A gene in 7 colorectal cancer cell lines and 95 paired cases of colorectal cancer and non-cancerous regions to demonstrate the importance of ATP11A expression in colorectal cancer prognosis. ATP11A was expressed in the 7 colorectal cancer cell lines. ATP11A mRNA expression was higher in colorectal cancer tissue than in corresponding normal tissue (P<0.001). Patients with high ATP11A expression showed a poorer disease-free survival rate compared to those with low expression (P<0.001), thus indicating that increase in ATP11A expression was an independent predictor of metachronous metastasis of colorectal cancer. The present study suggests that ATP11A is a useful predictive marker of metastasis in colorectal cancer patients.

29 May 2017 in Surgery Today
Verified
Journal Article
Closed access
PDF file
SIShuhei Ito
Shuhei Ito
YKYuichiro Kai
Yuichiro Kai
TMTakaaki Masuda
Takaaki Masuda
FTFumiaki Tanaka
Fumiaki Tanaka
TMToshifumi Matsumoto
Toshifumi Matsumoto
MMMasaki Mori
Masaki Mori

25 May 2011 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
MMMasaki Mori
Masaki Mori
FTFumiaki Tanaka
Fumiaki Tanaka
SMShinji Matsuzaki
Shinji Matsuzaki
KMKoshi Mimori
Koshi Mimori
YKYoshiaki Kita
Yoshiaki Kita
HIHiroshi Inoue
Hiroshi Inoue
CDC28 protein kinase regulatory subunit 2 (CKS2) is a cyclin-dependent kinase subunit (CKS) family member that participates in cell cycle regulation. Few studies have investigated its involvement in gastric cancer. In this study, we focused on the clinical and biological significance of CKS2 over-expression in gastric cancer. The expression of CKS2 mRNA was studied by real-time quantitative reverse transcription polymerase chain reaction, and the expression status in each tumor was examined to varify whether any correlation existed with clinical and pathological factors. In addition, an immuno-histochemical study was performed in selected samples. Moreover, we examined the impact of CKS2-siRNA in a gastric cancer cell line. A significantly higher expression of CKS2 mRNA was found in tumor tissues compared to paired normal tissues (p<0.01). Immunohistochemical analyses led to similar results. The overall five-year survival rate was significantly higher in the low CKS2 expression group (59.9%) than in the high CKS2 expression group (23.9%) (p<0.01). Univariate and multivariate analysis showed that CKS2 expression status was an independent prognostic factor (relative risk, 1.41; 95% confidence interval, 1.01-1.97; p<0.05). Moreover, the inhibition of cellular proliferation by CKS2-siRNA was observed in a gastric cancer cell line. CKS2 is one of the gastric cancer-related genes that correlates with biological aggressiveness and poor prognosis of gastric cancer. Thus, CKS2 is a possible candidate gene for diagnosis, as well as targeted molecular diagnosis and therapy in gastric cancer.